Detalhe da pesquisa
1.
One Step Forward: Successful End-of-Treatment Outcomes of Patients With Drug-Resistant Tuberculosis Who Received Concomitant Bedaquiline and Delamanid in Mumbai, India.
Clin Infect Dis
; 73(9): e3496-e3504, 2021 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33079176
2.
Correction: Ambulatory management of pre- and extensively drug resistant tuberculosis patients with imipenem delivered through port-a-cath: A mixed methods study on treatment outcomes and challenges.
PLoS One
; 19(2): e0299477, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38381762
3.
Correction: Challenging drug-resistant TB treatment journey for children, adolescents and their care-givers: A qualitative study.
PLoS One
; 19(2): e0299482, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38381772
4.
Challenging drug-resistant TB treatment journey for children, adolescents and their care-givers: A qualitative study.
PLoS One
; 16(3): e0248408, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33690715
5.
Treatment outcomes of children and adolescents receiving drug-resistant TB treatment in a routine TB programme, Mumbai, India.
PLoS One
; 16(2): e0246639, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33600431
6.
Ambulatory management of pre- and extensively drug resistant tuberculosis patients with imipenem delivered through port-a-cath: A mixed methods study on treatment outcomes and challenges.
PLoS One
; 15(6): e0234651, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32544174